RU2002109368A - A method of treating addiction - Google Patents

A method of treating addiction

Info

Publication number
RU2002109368A
RU2002109368A RU2002109368/14A RU2002109368A RU2002109368A RU 2002109368 A RU2002109368 A RU 2002109368A RU 2002109368/14 A RU2002109368/14 A RU 2002109368/14A RU 2002109368 A RU2002109368 A RU 2002109368A RU 2002109368 A RU2002109368 A RU 2002109368A
Authority
RU
Russia
Prior art keywords
administered intravenously
day
atropine sulfate
solution
atropine
Prior art date
Application number
RU2002109368/14A
Other languages
Russian (ru)
Other versions
RU2227031C2 (en
Inventor
Николай Васильевич Воробьев
Original Assignee
Николай Васильевич Воробьев
Filing date
Publication date
Application filed by Николай Васильевич Воробьев filed Critical Николай Васильевич Воробьев
Priority to RU2002109368/14A priority Critical patent/RU2227031C2/en
Priority claimed from RU2002109368/14A external-priority patent/RU2227031C2/en
Publication of RU2002109368A publication Critical patent/RU2002109368A/en
Application granted granted Critical
Publication of RU2227031C2 publication Critical patent/RU2227031C2/en

Links

Claims (1)

Способ лечения наркомании, отличающийся тем, что применяют атропино-коматозную и электросудорожную терапии через день, для этого, в нечетные дни, начиная с первого, предварительно больному в день лечения утром натощак за 30 минут до инъекции раствора атропина сульфата вводят внутривенно 5 мг галоперидола, 2 г оксибутирата натрия, 25 г тризерцина, а в конъюнктивальные мешки обоих глаз закладывают эзериновую мазь, затем внутривенно в виде 1%-ного раствора вводят 50-75 мг атропина сульфата, а потом, при каждом последующем сеансе, дозу атропина сульфата увеличивают на 10 мг, доводя к концу курса до средней 70-150 мг, или максимальной 90-170 мг коматозной дозы, далее внутривенно капельно вводят 15-30 мг физостигмина, и 6 г пирацетама, 7,5 г магния сульфата, 400 мл гипохлорита натрия, а в каждые четные дни, начиная со второго, больному предварительно внутривенно вводят 1 мл 0,1%-ного раствора атропина сульфата и 2 мл кордиамина, затем осуществляют вводный наркоз: внутривенно вводят 200-300 мг тиопентал-натрия или 100 мг кетамина, одновременно внутривенно применяют 3-4 мл 2%-ного дитилина, затем на височные области на середину линии от наружного края глаза до козелка накладывают электроды, предварительно смоченные в физиологическом растворе, и подают электрический импульс, средняя дозировка которого составляет 46-130 импульсов, а максимальная до 260, после чего проводят искусственную вентиляцию легких.A method for the treatment of drug addiction, characterized in that atropine-coma and electroconvulsive therapy are used every other day, for this, on odd days, starting from the first patient previously on the day of treatment in the morning on an empty stomach, 30 mg of haloperidol is administered intravenously 30 minutes before the injection of atropine sulfate solution, 2 g of sodium oxybutyrate, 25 g of triterzine, and an eserin ointment is placed in the conjunctival sacs of both eyes, then 50-75 mg of atropine sulfate is administered intravenously as a 1% solution, and then, with each subsequent session, a dose of atropine sulfate ata is increased by 10 mg, bringing to the end of the course to an average of 70-150 mg, or a maximum of 90-170 mg of a coma dose, then 15-30 mg of physostigmine and 6 g of piracetam, 7.5 g of magnesium sulfate, 400 ml are injected dropwise. sodium hypochlorite, and on every even day, starting from the second, the patient is pre-intravenously injected with 1 ml of a 0.1% solution of atropine sulfate and 2 ml of cordiamine, then anesthesia is administered: 200-300 mg of thiopental sodium or 100 mg are administered intravenously ketamine, 3-4 ml of 2% dithylin are simultaneously administered intravenously, then on the temporal areas In the middle of the line from the outer edge of the eye to the tragus, electrodes are applied, previously wetted in physiological saline, and an electrical impulse is applied, the average dosage of which is 46-130 impulses, and the maximum dosage is up to 260, after which artificial lung ventilation is performed.
RU2002109368/14A 2002-04-10 2002-04-10 Method for treatment of narcomania RU2227031C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002109368/14A RU2227031C2 (en) 2002-04-10 2002-04-10 Method for treatment of narcomania

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002109368/14A RU2227031C2 (en) 2002-04-10 2002-04-10 Method for treatment of narcomania

Publications (2)

Publication Number Publication Date
RU2002109368A true RU2002109368A (en) 2003-11-20
RU2227031C2 RU2227031C2 (en) 2004-04-20

Family

ID=32465042

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002109368/14A RU2227031C2 (en) 2002-04-10 2002-04-10 Method for treatment of narcomania

Country Status (1)

Country Link
RU (1) RU2227031C2 (en)

Similar Documents

Publication Publication Date Title
IL208184A0 (en) Glp-1, and methods for treating diabetes
EP4178569A1 (en) Method of treatment for psilocybin or psilocin infusion
WO2024040935A1 (en) Use of sacubitril/valsartan substance in preparation of drug for drug addiction and relapse
RU2002109368A (en) A method of treating addiction
RU2010152972A (en) METHOD FOR TREATING ACUTE DISORDER OF BRAIN AND SPIN BLOOD CIRCULATION OF ISCHEMIC AND HEMORRHAGIC CHARACTER
RU2487737C1 (en) Method of treating gastric or duodenal ulcer
RU2003125548A (en) METHOD FOR TREATMENT OF ADDICTIONS
CN1049602C (en) Compound injection for curing ischemic eye disease
CN1839834A (en) Eye medicine for preventing and treating asthenopia and allergy
RU2067446C1 (en) Method for treating pain syndrome in the cases of trifacial neuralgia and extremity stump phantom pain
RU2195272C1 (en) Method for treating neuritis of auditory nerve
SU1076124A1 (en) Method of treatment of acute pancreatitis
CN1189173C (en) Novel use of phencynonate hydrochloride
RU2462280C1 (en) Method for cytoflavin electric accumulation in treating vascular and dystrophic retinal and visual nerve diseases
RU2236223C2 (en) Method of treating larynx movement disorders
SU936916A1 (en) Method of treating paradontosis
CN1875968A (en) Application of anisodamine in preparation of smoking-stopping medicament
RU2002111320A (en) A method for the treatment of diseases of the nervous system
RU2233657C2 (en) Method for treatment of lichen ruber planus
SU1475668A1 (en) Method of treating functional lesions of facial nerve
RU2262959C1 (en) Method for treating patients for exacerbated neurologic diseases
RU2377995C1 (en) Method for treatment of calves suffering from dyspepsia with correction of pathological thrombocyte activation
RU2004111044A (en) DRUG FOR TREATMENT OF A HEMORRHAGIC STROKE AND METHOD FOR TREATING A HEMORRHAGIC STROKE
RU2000108520A (en) METHOD FOR RESTORING TREATMENT OF OSTEOARTHROSIS PATIENTS
RU94035493A (en) Method for treating diskal lumbosacral and other types of intervertebral hernias